Supporting your practice at every step

Experience mental healthcare with a new approach

Through the unique healing and transformative experiences of psychedelic-assisted therapy, we are witnessing a new frontier of treatment that is providing hope to those struggling with mental health concerns.

SUBSCRIBE TO OUR NEWSLETTER

Discover the new psychedelic landscape

The key to the safe and ethical delivery of psychedelic-assisted therapy is having it administered by a skilled therapist. We give patients the confidence that their therapist has been trained in psychedelic-assisted therapy with the highest degree of professionalism and integrity.

Creating a standard for which psychedelic therapists should be trained is an important step in the evolution of this field. Healthcare professionals who achieve competency in this area will be able to adopt this treatment into their practice upon legalization of these medicines.

We're here to help you get started

Globally renowned leaders in the medical community have partnered with ATMA to develop the curricula, training models, and lectures for the course offerings.

We currently offer an Introduction to Psychedelic-assisted Therapy Course, with several other programs currently in development, including the Psilocybin-assisted Therapy Program starting Fall 2022.

REGISTER NOW

Introduction to Psychedelic-assisted Therapy

This CE credited course offers an overview of psychedelic medicines in a convenient manner, allowing for healthcare professionals to gain familiarity with psychedelic medicine.

LEARN MORE

Advanced Psychedelic Training

This program will provide the opportunity for legal experiential training under the supervision of skilled psychedelic guides and medical practitioners.

The Introduction to Psychedelic-assisted Therapy course is a prerequisite for this program.

LEARN MORE

This program has not only done a masterful job of setting the foundations for psychedelic-assisted therapy, but also helped connect participants with like-minded health providers and fostered a continued interest in exploring this needed healing modality at an even deeper level.

MIKAEL BARTHOLDY

ATMA ALUMNI

The richness of the experience, expertise and discussion was deeply meaningful. Thank you ATMA.

ALISON BELL

ATMA ALUMNI

Great format of watching presentations ahead of time for the Q&A’s and then speaking to the amazing presenters about their experiences. Wonderful to connect with other therapists and interested individuals through breakout groups.

MAYA SLOAN

ATMA ALUMNI

So informative and a must if you are interested in becoming a psychedelic therapist.

CAROLDEAN JUDE

ATMA ALUMNI

It’s wonderful to be on live Zoom calls with so many amazing teachers. Thank you all, so much gratitude for this space!

KAROLINA MIKOS

ATMA ALUMNI

Meet your instructors

Our teaching faculty features a number of leading experts in their respective fields.

Leading clinical trials and research

Health Canada has approved our Phase I Study that aims to assess the safety of psilocybin in healthcare workers.

Our Phase II Study aims to assess the efficacy of psilocybin in treating frontline healthcare workers presenting with COVID-19-related depression, anxiety, or burnout has recently been submitted to Health Canada for approval.

Lastly, we plan to conduct future studies with palliative care patients experiencing end-of-life anxiety.

LEARN MORE

Building the largest online community platform for psychedelic therapy practitioners

By offering a clear, guided path for therapy providers to practicably adopt psychedelic-assisted therapy

A supportive environment fosters higher levels of engagement; the sharing of data and experiences will lead to increased efficacy and will inform best practice

Attracts more therapy providers to adopt psychedelic assisted therapy and to engage in the community

Join and connect with the community

Share data and experiences, facilitate group discussions, find support services and stay up-to-date with emerging research. With our community platform, we provide a solution for therapists looking to connect and network with one another. Our platform will continually support therapists, whether operating in a clinic or working independently. 

ATMA Academy Alumni will have access to these community-based platforms, allowing for them to be actively involved in the psychedelic community and to be part of the paradigm shift the world is experiencing.

New Book Out by Murray Rodgers!

The Psychedelic CEO

Official Book Website
Book and Reviews on Amazon

Be the first to know

Stay informed on our various initiatives and offerings

500, 2303 4 St SW
Calgary, Alberta, Canada
Phone: (403) 278-9020

Facebook Twitter Instagram Linkedin

Company

Programs

Resources

Scroll to Top

Dr. Anthony Bossis is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine. He is Director of Palliative Care Research, Co-Principal Investigator, and a session guide for the NYU Psilocybin Cancer Anxiety Project, a FDA-approved clinical trial investigating the efficacy of a psilocybin-generated mystical experience upon existential and psycho-spiritual distress in persons with cancer.

Dr. Megan McElheran is the CEO and Chief Clinical Psychologist of Wayfound Mental Health Group. Dr. McElheran completed graduate training at the PAU-Stanford University Clinical Psychology Consortium, during which she obtained specialized training in the treatment of PTSD through the National Center for PTSD in Menlo Park, CA. Dr. McElheran has been in practice in Calgary since 2008. She continues to focus on work with first responders, and her clinical practice involves work with active-duty members of the Canadian Forces, members of the Royal Canadian Mounted Police, members of the Calgary Firefighter Department, medical personnel, and others who are directly or vicariously impacted by traumatic events. She routinely engages in teaching and supervisory activity to ensure the sound dissemination of empirically-grounded interventions for trauma. Dr. McElheran is regularly engaged in speaking events, both locally and internationally. She completed a TEDx speech in 2011 related to Trauma, Change, and Resilience and most recently completed a discussion for the Healing Project on trauma and PTSD.

Natalie has a deep passion for creating spaces for people to feel safe and open for personal transformation. Her experiences as an on-air radio personality, years as an on-air television journalist producing and directing a weekly show as well as contributing to a daily live program for a national television station, allowed her to witness literally hundreds of peoples individual stories. In addition to these public roles, she managed multiple television station locations, designed and oversaw studio expansions, managed a program for artists and musicians with an international humanitarian organization, after which she started and ran her own successful company focused on personal health and wellness for 6 years.

David has worked full-time for the past 5 years in researching, advocating and moving the work of non-ordinary state therapy and psychedelic medicine forward in Canada. He co-founded and led Catalyst Presents, a Psychedelic Research Conference, and ATMA Journey Centers, a Canadian non-profit dedicated to bringing psychedelic-assisted therapy to Canadians which was successful in achieving one of Canada’s first modern legal exemptions to undertake psychedelic-assisted work. With a Master’s degree in religious studies and having been both a college professor and international humanitarian relief worker, David has always dedicated himself to the service of others. He brings a deep experience and reverence for psychedelic medicine and believes that it will play a key role in bringing healing to humanity.

Mike is an addiction and trauma therapist with 15 years of experience working in residential and outpatient treatment programs with both individuals and groups. His therapeutic ethos focuses on offering the development of evidence-based skills as well as support to integrate these skills so that his clients may realize a more fulfilling life. He practices a blend of approaches including motivational interviewing, acceptance and commitment therapy (ACT) and existential therapy. Mike believes in the transformative power of psychedelic medicines to connect people with their inner healing intelligence and the embodied wisdom accessible to all. He recognizes the importance of a safe container being created (including preparation and integration), and values how this supports the development of psychological flexibility, potentially leading to profound and lasting improvements in the person’s quality of life via behavioural change.

Mike has been working with first responders for the past 2 years facilitating PTSD healing groups. His recent efforts have been focused on the development of Resilient Living Recovery (RLR), a 10 week online addiction treatment program for people with mild to moderate substance use problems. Since 2018, Mike has presented at the Spirit Plant Medicine Conference and has been training as a study therapist for clinical research led by the Multidisciplinary Association for Psychedelic Studies (MAPS) on a clinical trial that will see the MAPS MDMA protocol for trauma applied to eating disorders. He has also been approved as a research therapist on a clinical trial with Numinous that will investigate the use of psilocybin for substance use disorders via motivational enhancement therapy. Mike has attended several psychedelic integration workshops and is a consultant for PsyGen Labs focusing on the therapeutic aspects pertaining to the development of psychedelic medicine clinical trials.

Trevor Millar is a social-entrepreneur who has played a key role in advancing the psychedelic movement for nearly a decade. He has the unique perspective of having operated a business where he legally administered psychedelics to over 200 people within Canada, mostly for substance use disorder. Since May 2018 he has been on the board of directors for the Multidisciplinary Association of Psychedelic Studies (MAPS) Canada, where he acted as Chair of the Board for over two years. MAPS is a non-profit organization and a leader in supporting scientific research into psychedelics. He is also currently a board member and co-founder of the Canadian Psychedelic Association.

From 2012 to 2017, Trevor was active as the founder and President of Liberty Root Therapy Inc., a business dedicated to healing and transformation by legally providing the plant medicine ibogaine to people mostly with opiate use disorder. Trevor was featured in the award-winning documentary about using magic mushrooms and Iboga to treat addiction, anxiety and depression called DOSED, which was released in 2019. He is currently the Chief Psychedelic Officer of NeonMind Biosciences Inc., a corporation dedicated to developing and commercializing products that contain legal medicinal mushrooms and those that may contain psychedelic compounds. Trevor is also on the Advisory Board of Nature Spirit Labs Inc.

Bruce Sanguin has been a Clinical Fellow with the Canadian Association of Marriage and Family Therapists for 25 years. He currently lives in Victoria, BC where he practices as a psychotherapist. He is the author of seven books, the latest of which, Dismantled: How Love and Psychedelics Broke a Clergyman Apart and Put Him Back Together, describes his own healing journey using psychedelics in the context of psychedelic-assisted psychotherapy. As well as practicing psychotherapy, Bruce is a keynote speaker at psychedelic conferences, with an active interest in the integration of spirituality and psychology.

Dr. Christie is a clinical instructor with the UBC Department of Medicine and a family physician with a focused practice in Multidisciplinary Pain Management. She is a Registered Therapeutic Counsellor emphasizing Relational Somatic Therapy for trauma resolution and is trained to deliver both MDMA-assisted psychotherapy for PTSD (MAPS USA) and ketamine-assisted psychotherapy, in a research setting. She is a recognized speaker and expert on the potential for incorporating psychedelic assisted therapies in an improved health care model for the future.

Dr. Ian Mitchell is an Emergency Physician working in Kamloops, BC and an Associate Clinical Professor at the UBC Department of Emergency Medicine. He has worked at St. Paul’s Hospital in Vancouver and in Abu Dhabi, UAE. He is interested in harm reduction and was the physician lead for the first emergency department distribution of Take Home Naloxone kits in Canada. He is a cannabis clinician and researcher, and was the qualified investigator in an RCT of cannabis for PTSD. He has been using ketamine as part of his emergency practice for 25 years and is on the board of directors for the Ketamine Assisted Therapy Association of Canada.

Dr. Saundra Jain is an Adjunct Clinical Affiliate, School of Nursing, at The University of Texas at Austin, and a psychotherapist in private practice. Dr. Jain is a co-creator of the WILD 5 Wellness Program and co-author of a well-received workbook written for those interested in improving their mental wellness – KickStart30: A Proven 30-Day Mental Wellness Program. She is co-creator of the Psychedelics and Wellness Survey (PAWS) exploring the intersect between psychedelics and wellness. She serves as a member of the Psych Congress Steering Committee providing direction regarding educational gaps/needs for mental health practitioners, and Sana Symposium providing psychedelics education for mental health and addiction professionals.

Dr. Erika Dyck is a Professor at the University of Saskatchewan, and a Canada Research Chair in the History of Medicine. She is the author of Psychedelic Psychiatry: LSD from Clinic to Campus (Johns Hopkins, 2008; University of Manitoba Press, 2011), Managing Madness: The Weyburn Mental Hospital and Transformations of Psychiatric Care in Canada (2017) and the co-editor of Culture’s Catalyst: Encounters with Peyote and the Native American Church in Canada (2016) and Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond (2018).

Mark Haden is an Adjunct professor at the University of British Columbia, School of Population and Public Health.

As the past Executive Director of MAPS Canada (Multidisciplinary Association for Psychedelic Studies), he has published on the issue of drug control policy and psychedelics in the following Journals: Canadian Journal of Public Health, International Journal of Drug Policy, Encyclopaedia of Public Health, Harm Reduction Journal, Open Medicine, Journal of Psychoactive Drugs, and the Journal of Studies on Alcohol and Drugs.

Mark teaches in the UBC school of medicine (Population and Public Health), obtained an MSW from UBC and worked for the Addiction Services for 28 years in counselling and supervisory roles. He has provided public education on drugs and drug policy for over 30 years and works with the Health Officers Council of British Columbia on their position papers on the issue of a regulated market for all currently illegal drugs.

He has presented in conferences and training events in many countries and was awarded the Queen’s Diamond Jubilee Medal for drug policy reform work in 2013.